# PathogenDx Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pathogendx

- Industry: Biotechnology
- Headquarters: Scottsdale, US
- Website: www.pathogendx.com
- Total disclosed funding: $7.5M
- Latest round: Series B (Sep 30, 2019)
- Investors on record: 6

## About

PathogenDx Corporation develops innovative pathogen detection technologies to enhance safety in various sectors, including cannabis, life sciences, and food safety, utilizing cutting-edge methods for accurate testing.Founded in 2015 and headquartered in Scottsdale, US, PathogenDx Corporation specializes in pathogen detection solutions. Milan Patel is the CEO and one of the founders. The company has raised a total of USD 7.5 mn through three funding deals, with the most recent being a Series B round on September 30, 2019, led by Entourage Effect Capital and joined by several other investors.PathogenDx specializes in advanced pathogen detection technologies, including the D³ Dynamic Dimensional Detection Array, which allows simultaneous identification of up to 100 pathogen targets. Their offerings also include specialized assays for pathogens like Salmonella and Listeria, catering to clients in laboratories, food manufacturing, agriculture, and cannabis sectors across the US, Canada, and select international markets.PathogenDx generates revenue through B2B sales of its proprietary testing products and services, including the D³ Dynamic Dimensional Detection Array and various pathogen-specific assays. Clients often engage in one-time purchases or subscription services, with a pricing structure designed to ensure competitive cost-per-sample rates compared to traditional testing methods.With the recent Series B funding of USD 7.5 mn secured in September 2019, PathogenDx plans to enhance its product offerings and expand into new markets. They are focusing on developing new pathogen detection solutions and increasing their market presence in the cannabis and food safety sectors, aiming for geographic expansion into Europe and Asia by 2022.

## Funding rounds

- Series B, Sep 30, 2019, $7.5M — Salveo Capital, Panther Opportunity Fund, Altitude Investment Management, Entourage Effect Capital, Flatiron Venture Partners, Arcadian Investment Partners

## Investors

- Salveo Capital (https://capitalatlas.ai/funds/salveo-capital) — Series B
- Panther Opportunity Fund (https://capitalatlas.ai/funds/panther-opportunity-fund) — Series B
- Altitude Investment Management (https://capitalatlas.ai/funds/altitude-investment-management) — Series B
- Entourage Effect Capital (https://capitalatlas.ai/funds/entourage-effect-capital) — Series B
- Flatiron Venture Partners (https://capitalatlas.ai/funds/flatiron-venture-partners) — Series B
- Arcadian Investment Partners (https://capitalatlas.ai/funds/arcadian-investment-partners) — Series B